Global Pregnancy Medication Market Research Report 2022

Publisher Name :
Date: 23-Nov-2022
No. of pages: 105
Inquire Before Buying

Highlights

The global Pregnancy Medication market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

North American market for Pregnancy Medication is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for Pregnancy Medication is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global manufacturers of Pregnancy Medication include Glenmark Pharmaceuticals Ltd, Roche Holding AG, Pfizer, Alkem Laboratories Limited, Lupin Limited, Piramal Enterprises Limited, Amgen Inc, AbbVie and Janssen, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

The global market for Pregnancy Medication in Hospital Pharmacy is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Antianemia, which accounted for % of the global market of Pregnancy Medication in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pregnancy Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pregnancy Medication.

The Pregnancy Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Pregnancy Medication market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pregnancy Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Glenmark Pharmaceuticals Ltd

- Roche Holding AG

- Pfizer

- Alkem Laboratories Limited

- Lupin Limited

- Piramal Enterprises Limited

- Amgen Inc

- AbbVie

- Janssen

- Regeneron

- Sanofi

- Sun Pharma

- Takeda

- Viatris Inc(Mylan Inc.)

- Dr. Reddy's Laboratories

- Alembic Pharmaceuticals Ltd

- Cipla Inc

- GSK

Product Type Insights

Global markets are presented by Pregnancy Medication type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Pregnancy Medication are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Pregnancy Medication segment by Type

- Antianemia

- Antacids

- Antiallergic

- Analgesics

- Antimicrobials

- Laxatives

- Vaccines

- Nutritional Supplements

- Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Pregnancy Medication market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Pregnancy Medication market.

Pregnancy Medication segment by Application

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Pregnancy Medication market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pregnancy Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Pregnancy Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Pregnancy Medication industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pregnancy Medication.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Pregnancy Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Pregnancy Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Analysis of sales channel, distributors and customers

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.

Chapter 11: The main points and conclusions of the report.

Global Pregnancy Medication Market Research Report 2022

Table of Contents
1 Pregnancy Medication Market Overview
1.1 Product Overview and Scope of Pregnancy Medication
1.2 Pregnancy Medication Segment by Type
1.2.1 Global Pregnancy Medication Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Antianemia
1.2.3 Antacids
1.2.4 Antiallergic
1.2.5 Analgesics
1.2.6 Antimicrobials
1.2.7 Laxatives
1.2.8 Vaccines
1.2.9 Nutritional Supplements
1.2.10 Others
1.3 Pregnancy Medication Segment by Application
1.3.1 Global Pregnancy Medication Sales Comparison by Application: (2022-2028)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Pregnancy Medication Market Size Estimates and Forecasts
1.4.1 Global Pregnancy Medication Revenue 2017-2028
1.4.2 Global Pregnancy Medication Sales 2017-2028
1.4.3 Pregnancy Medication Market Size by Region: 2017 Versus 2021 Versus 2028
2 Pregnancy Medication Market Competition by Manufacturers
2.1 Global Pregnancy Medication Sales Market Share by Manufacturers (2017-2022)
2.2 Global Pregnancy Medication Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Pregnancy Medication Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Pregnancy Medication Manufacturing Sites, Area Served, Product Type
2.5 Pregnancy Medication Market Competitive Situation and Trends
2.5.1 Pregnancy Medication Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pregnancy Medication Players Market Share by Revenue
2.5.3 Global Pregnancy Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pregnancy Medication Retrospective Market Scenario by Region
3.1 Global Pregnancy Medication Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Pregnancy Medication Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Pregnancy Medication Market Facts & Figures by Country
3.3.1 North America Pregnancy Medication Sales by Country
3.3.2 North America Pregnancy Medication Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Pregnancy Medication Market Facts & Figures by Country
3.4.1 Europe Pregnancy Medication Sales by Country
3.4.2 Europe Pregnancy Medication Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pregnancy Medication Market Facts & Figures by Region
3.5.1 Asia Pacific Pregnancy Medication Sales by Region
3.5.2 Asia Pacific Pregnancy Medication Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Pregnancy Medication Market Facts & Figures by Country
3.6.1 Latin America Pregnancy Medication Sales by Country
3.6.2 Latin America Pregnancy Medication Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pregnancy Medication Market Facts & Figures by Country
3.7.1 Middle East and Africa Pregnancy Medication Sales by Country
3.7.2 Middle East and Africa Pregnancy Medication Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pregnancy Medication Historic Market Analysis by Type
4.1 Global Pregnancy Medication Sales Market Share by Type (2017-2022)
4.2 Global Pregnancy Medication Revenue Market Share by Type (2017-2022)
4.3 Global Pregnancy Medication Price by Type (2017-2022)
5 Global Pregnancy Medication Historic Market Analysis by Application
5.1 Global Pregnancy Medication Sales Market Share by Application (2017-2022)
5.2 Global Pregnancy Medication Revenue Market Share by Application (2017-2022)
5.3 Global Pregnancy Medication Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Glenmark Pharmaceuticals Ltd
6.1.1 Glenmark Pharmaceuticals Ltd Corporation Information
6.1.2 Glenmark Pharmaceuticals Ltd Description and Business Overview
6.1.3 Glenmark Pharmaceuticals Ltd Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Glenmark Pharmaceuticals Ltd Pregnancy Medication Product Portfolio
6.1.5 Glenmark Pharmaceuticals Ltd Recent Developments/Updates
6.2 Roche Holding AG
6.2.1 Roche Holding AG Corporation Information
6.2.2 Roche Holding AG Description and Business Overview
6.2.3 Roche Holding AG Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Roche Holding AG Pregnancy Medication Product Portfolio
6.2.5 Roche Holding AG Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pfizer Pregnancy Medication Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Alkem Laboratories Limited
6.4.1 Alkem Laboratories Limited Corporation Information
6.4.2 Alkem Laboratories Limited Description and Business Overview
6.4.3 Alkem Laboratories Limited Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Alkem Laboratories Limited Pregnancy Medication Product Portfolio
6.4.5 Alkem Laboratories Limited Recent Developments/Updates
6.5 Lupin Limited
6.5.1 Lupin Limited Corporation Information
6.5.2 Lupin Limited Description and Business Overview
6.5.3 Lupin Limited Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Lupin Limited Pregnancy Medication Product Portfolio
6.5.5 Lupin Limited Recent Developments/Updates
6.6 Piramal Enterprises Limited
6.6.1 Piramal Enterprises Limited Corporation Information
6.6.2 Piramal Enterprises Limited Description and Business Overview
6.6.3 Piramal Enterprises Limited Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Piramal Enterprises Limited Pregnancy Medication Product Portfolio
6.6.5 Piramal Enterprises Limited Recent Developments/Updates
6.7 Amgen Inc
6.6.1 Amgen Inc Corporation Information
6.6.2 Amgen Inc Description and Business Overview
6.6.3 Amgen Inc Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Amgen Inc Pregnancy Medication Product Portfolio
6.7.5 Amgen Inc Recent Developments/Updates
6.8 AbbVie
6.8.1 AbbVie Corporation Information
6.8.2 AbbVie Description and Business Overview
6.8.3 AbbVie Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.8.4 AbbVie Pregnancy Medication Product Portfolio
6.8.5 AbbVie Recent Developments/Updates
6.9 Janssen
6.9.1 Janssen Corporation Information
6.9.2 Janssen Description and Business Overview
6.9.3 Janssen Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Janssen Pregnancy Medication Product Portfolio
6.9.5 Janssen Recent Developments/Updates
6.10 Regeneron
6.10.1 Regeneron Corporation Information
6.10.2 Regeneron Description and Business Overview
6.10.3 Regeneron Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Regeneron Pregnancy Medication Product Portfolio
6.10.5 Regeneron Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Corporation Information
6.11.2 Sanofi Pregnancy Medication Description and Business Overview
6.11.3 Sanofi Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Sanofi Pregnancy Medication Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Sun Pharma
6.12.1 Sun Pharma Corporation Information
6.12.2 Sun Pharma Pregnancy Medication Description and Business Overview
6.12.3 Sun Pharma Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Sun Pharma Pregnancy Medication Product Portfolio
6.12.5 Sun Pharma Recent Developments/Updates
6.13 Takeda
6.13.1 Takeda Corporation Information
6.13.2 Takeda Pregnancy Medication Description and Business Overview
6.13.3 Takeda Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Takeda Pregnancy Medication Product Portfolio
6.13.5 Takeda Recent Developments/Updates
6.14 Viatris Inc(Mylan Inc.)
6.14.1 Viatris Inc(Mylan Inc.) Corporation Information
6.14.2 Viatris Inc(Mylan Inc.) Pregnancy Medication Description and Business Overview
6.14.3 Viatris Inc(Mylan Inc.) Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Viatris Inc(Mylan Inc.) Pregnancy Medication Product Portfolio
6.14.5 Viatris Inc(Mylan Inc.) Recent Developments/Updates
6.15 Dr. Reddy's Laboratories
6.15.1 Dr. Reddy's Laboratories Corporation Information
6.15.2 Dr. Reddy's Laboratories Pregnancy Medication Description and Business Overview
6.15.3 Dr. Reddy's Laboratories Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Dr. Reddy's Laboratories Pregnancy Medication Product Portfolio
6.15.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.16 Alembic Pharmaceuticals Ltd
6.16.1 Alembic Pharmaceuticals Ltd Corporation Information
6.16.2 Alembic Pharmaceuticals Ltd Pregnancy Medication Description and Business Overview
6.16.3 Alembic Pharmaceuticals Ltd Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Alembic Pharmaceuticals Ltd Pregnancy Medication Product Portfolio
6.16.5 Alembic Pharmaceuticals Ltd Recent Developments/Updates
6.17 Cipla Inc
6.17.1 Cipla Inc Corporation Information
6.17.2 Cipla Inc Pregnancy Medication Description and Business Overview
6.17.3 Cipla Inc Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Cipla Inc Pregnancy Medication Product Portfolio
6.17.5 Cipla Inc Recent Developments/Updates
6.18 GSK
6.18.1 GSK Corporation Information
6.18.2 GSK Pregnancy Medication Description and Business Overview
6.18.3 GSK Pregnancy Medication Sales, Revenue and Gross Margin (2017-2022)
6.18.4 GSK Pregnancy Medication Product Portfolio
6.18.5 GSK Recent Developments/Updates
7 Pregnancy Medication Manufacturing Cost Analysis
7.1 Pregnancy Medication Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pregnancy Medication
7.4 Pregnancy Medication Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pregnancy Medication Distributors List
8.3 Pregnancy Medication Customers
9 Pregnancy Medication Market Dynamics
9.1 Pregnancy Medication Industry Trends
9.2 Pregnancy Medication Market Drivers
9.3 Pregnancy Medication Market Challenges
9.4 Pregnancy Medication Market Restraints
10 Global Market Forecast
10.1 Pregnancy Medication Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pregnancy Medication by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Pregnancy Medication by Type (2023-2028)
10.2 Pregnancy Medication Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pregnancy Medication by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Pregnancy Medication by Application (2023-2028)
10.3 Pregnancy Medication Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pregnancy Medication by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Pregnancy Medication by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Pregnancy Medication Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Pregnancy Medication Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Pregnancy Medication Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Pregnancy Medication Market Competitive Situation by Manufacturers in 2021
Table 5. Global Pregnancy Medication Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Pregnancy Medication Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Pregnancy Medication Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Pregnancy Medication Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Pregnancy Medication Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Pregnancy Medication Manufacturing Sites and Area Served
Table 11. Manufacturers Pregnancy Medication Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pregnancy Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pregnancy Medication as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pregnancy Medication Sales by Region (2017-2022) & (K Units)
Table 16. Global Pregnancy Medication Sales Market Share by Region (2017-2022)
Table 17. Global Pregnancy Medication Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Pregnancy Medication Revenue Market Share by Region (2017-2022)
Table 19. North America Pregnancy Medication Sales by Country (2017-2022) & (K Units)
Table 20. North America Pregnancy Medication Sales Market Share by Country (2017-2022)
Table 21. North America Pregnancy Medication Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Pregnancy Medication Revenue Market Share by Country (2017-2022)
Table 23. Europe Pregnancy Medication Sales by Country (2017-2022) & (K Units)
Table 24. Europe Pregnancy Medication Sales Market Share by Country (2017-2022)
Table 25. Europe Pregnancy Medication Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Pregnancy Medication Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Pregnancy Medication Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Pregnancy Medication Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Pregnancy Medication Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Pregnancy Medication Revenue Market Share by Region (2017-2022)
Table 31. Latin America Pregnancy Medication Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Pregnancy Medication Sales Market Share by Country (2017-2022)
Table 33. Latin America Pregnancy Medication Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Pregnancy Medication Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Pregnancy Medication Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Pregnancy Medication Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Pregnancy Medication Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Pregnancy Medication Revenue Market Share by Country (2017-2022)
Table 39. Global Pregnancy Medication Sales by Type (2017-2022) & (K Units)
Table 40. Global Pregnancy Medication Sales Market Share by Type (2017-2022)
Table 41. Global Pregnancy Medication Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Pregnancy Medication Revenue Share by Type (2017-2022)
Table 43. Global Pregnancy Medication Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Pregnancy Medication Sales (K Units) by Application (2017-2022)
Table 45. Global Pregnancy Medication Sales Market Share by Application (2017-2022)
Table 46. Global Pregnancy Medication Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Pregnancy Medication Revenue Share by Application (2017-2022)
Table 48. Global Pregnancy Medication Price by Application (2017-2022) & (US$/Unit)
Table 49. Glenmark Pharmaceuticals Ltd Corporation Information
Table 50. Glenmark Pharmaceuticals Ltd Description and Business Overview
Table 51. Glenmark Pharmaceuticals Ltd Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Glenmark Pharmaceuticals Ltd Pregnancy Medication Product
Table 53. Glenmark Pharmaceuticals Ltd Recent Developments/Updates
Table 54. Roche Holding AG Corporation Information
Table 55. Roche Holding AG Description and Business Overview
Table 56. Roche Holding AG Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Roche Holding AG Pregnancy Medication Product
Table 58. Roche Holding AG Recent Developments/Updates
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Pfizer Pregnancy Medication Product
Table 63. Pfizer Recent Developments/Updates
Table 64. Alkem Laboratories Limited Corporation Information
Table 65. Alkem Laboratories Limited Description and Business Overview
Table 66. Alkem Laboratories Limited Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Alkem Laboratories Limited Pregnancy Medication Product
Table 68. Alkem Laboratories Limited Recent Developments/Updates
Table 69. Lupin Limited Corporation Information
Table 70. Lupin Limited Description and Business Overview
Table 71. Lupin Limited Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Lupin Limited Pregnancy Medication Product
Table 73. Lupin Limited Recent Developments/Updates
Table 74. Piramal Enterprises Limited Corporation Information
Table 75. Piramal Enterprises Limited Description and Business Overview
Table 76. Piramal Enterprises Limited Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Piramal Enterprises Limited Pregnancy Medication Product
Table 78. Piramal Enterprises Limited Recent Developments/Updates
Table 79. Amgen Inc Corporation Information
Table 80. Amgen Inc Description and Business Overview
Table 81. Amgen Inc Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Amgen Inc Pregnancy Medication Product
Table 83. Amgen Inc Recent Developments/Updates
Table 84. AbbVie Corporation Information
Table 85. AbbVie Description and Business Overview
Table 86. AbbVie Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. AbbVie Pregnancy Medication Product
Table 88. AbbVie Recent Developments/Updates
Table 89. Janssen Corporation Information
Table 90. Janssen Description and Business Overview
Table 91. Janssen Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Janssen Pregnancy Medication Product
Table 93. Janssen Recent Developments/Updates
Table 94. Regeneron Corporation Information
Table 95. Regeneron Description and Business Overview
Table 96. Regeneron Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Regeneron Pregnancy Medication Product
Table 98. Regeneron Recent Developments/Updates
Table 99. Sanofi Corporation Information
Table 100. Sanofi Description and Business Overview
Table 101. Sanofi Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Sanofi Pregnancy Medication Product
Table 103. Sanofi Recent Developments/Updates
Table 104. Sun Pharma Corporation Information
Table 105. Sun Pharma Description and Business Overview
Table 106. Sun Pharma Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Sun Pharma Pregnancy Medication Product
Table 108. Sun Pharma Recent Developments/Updates
Table 109. Takeda Corporation Information
Table 110. Takeda Description and Business Overview
Table 111. Takeda Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Takeda Pregnancy Medication Product
Table 113. Takeda Recent Developments/Updates
Table 114. Viatris Inc(Mylan Inc.) Corporation Information
Table 115. Viatris Inc(Mylan Inc.) Description and Business Overview
Table 116. Viatris Inc(Mylan Inc.) Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Viatris Inc(Mylan Inc.) Pregnancy Medication Product
Table 118. Viatris Inc(Mylan Inc.) Recent Developments/Updates
Table 119. Dr. Reddy's Laboratories Corporation Information
Table 120. Dr. Reddy's Laboratories Description and Business Overview
Table 121. Dr. Reddy's Laboratories Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Dr. Reddy's Laboratories Pregnancy Medication Product
Table 123. Dr. Reddy's Laboratories Recent Developments/Updates
Table 124. Alembic Pharmaceuticals Ltd Corporation Information
Table 125. Alembic Pharmaceuticals Ltd Description and Business Overview
Table 126. Alembic Pharmaceuticals Ltd Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Alembic Pharmaceuticals Ltd Pregnancy Medication Product
Table 128. Alembic Pharmaceuticals Ltd Recent Developments/Updates
Table 129. Cipla Inc Corporation Information
Table 130. Cipla Inc Description and Business Overview
Table 131. Cipla Inc Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Cipla Inc Pregnancy Medication Product
Table 133. Cipla Inc Recent Developments/Updates
Table 134. GSK Corporation Information
Table 135. GSK Description and Business Overview
Table 136. GSK Pregnancy Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. GSK Pregnancy Medication Product
Table 138. GSK Recent Developments/Updates
Table 139. Production Base and Market Concentration Rate of Raw Material
Table 140. Key Suppliers of Raw Materials
Table 141. Pregnancy Medication Distributors List
Table 142. Pregnancy Medication Customers List
Table 143. Pregnancy Medication Market Trends
Table 144. Pregnancy Medication Market Drivers
Table 145. Pregnancy Medication Market Challenges
Table 146. Pregnancy Medication Market Restraints
Table 147. Global Pregnancy Medication Sales Forecast by Type (2023-2028) & (K Units)
Table 148. Global Pregnancy Medication Sales Market Share Forecast by Type (2023-2028)
Table 149. Global Pregnancy Medication Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 150. Global Pregnancy Medication Revenue Market Share Forecast by Type (2023-2028)
Table 151. Global Pregnancy Medication Sales Forecast by Application (2023-2028) & (K Units)
Table 152. Global Pregnancy Medication Sales Market Share Forecast by Application (2023-2028)
Table 153. Global Pregnancy Medication Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 154. Global Pregnancy Medication Revenue Market Share Forecast by Application (2023-2028)
Table 155. Global Pregnancy Medication Sales Forecast by Region (2023-2028) & (K Units)
Table 156. Global Pregnancy Medication Sales Market Share Forecast by Region (2023-2028)
Table 157. Global Pregnancy Medication Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 158. Global Pregnancy Medication Revenue Market Share Forecast by Region (2023-2028)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pregnancy Medication
Figure 2. Global Pregnancy Medication Market Share by Type in 2021 & 2028
Figure 3. Antianemia Product Picture
Figure 4. Antacids Product Picture
Figure 5. Antiallergic Product Picture
Figure 6. Analgesics Product Picture
Figure 7. Antimicrobials Product Picture
Figure 8. Laxatives Product Picture
Figure 9. Vaccines Product Picture
Figure 10. Nutritional Supplements Product Picture
Figure 11. Others Product Picture
Figure 12. Global Pregnancy Medication Market Share by Application in 2021 & 2028
Figure 13. Hospital Pharmacy
Figure 14. Retail Pharmacy
Figure 15. Online Pharmacy
Figure 16. Global Pregnancy Medication Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Pregnancy Medication Market Size (2017-2028) & (US$ Million)
Figure 18. Global Pregnancy Medication Sales (2017-2028) & (K Units)
Figure 19. Pregnancy Medication Sales Share by Manufacturers in 2021
Figure 20. Global Pregnancy Medication Revenue Share by Manufacturers in 2021
Figure 21. The Global 5 and 10 Largest Pregnancy Medication Players: Market Share by Revenue in 2021
Figure 22. Pregnancy Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global Pregnancy Medication Sales Market Share by Region (2017-2022)
Figure 24. Global Pregnancy Medication Sales Market Share by Region in 2021
Figure 25. Global Pregnancy Medication Revenue Market Share by Region (2017-2022)
Figure 26. Global Pregnancy Medication Revenue Market Share by Region in 2021
Figure 27. United States Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Canada Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Germany Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. France Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. U.K. Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Italy Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Russia Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Japan Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. South Korea Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. India Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Australia Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. China Taiwan Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Indonesia Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Thailand Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Malaysia Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Mexico Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Brazil Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Argentina Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Turkey Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Saudi Arabia Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. UAE Pregnancy Medication Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. Sales Market Share of Pregnancy Medication by Type (2017-2022)
Figure 50. Manufacturing Cost Structure of Pregnancy Medication
Figure 51. Manufacturing Process Analysis of Pregnancy Medication
Figure 52. Pregnancy Medication Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs